Guided Therapeutics, Inc. (GTHP)
OTCMKTS
· Delayed Price · Currency is USD
0.1000
0.00 (0.00%)
Apr 24, 2025, 3:00 PM EDT
Guided Therapeutics Company Description
Guided Therapeutics, Inc., a medical technology company, develops medical devices.
It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008.
Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.
Guided Therapeutics, Inc.
| Country | United States |
| Founded | 1992 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Mark Faupel |
Contact Details
Address: 5835 Peachtree Corners East Peachtree Corners, Delaware 30092 United States | |
| Phone | 770 242 8723 |
| Website | guidedinc.com |
Stock Details
| Ticker Symbol | GTHP |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US40171F5017 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Mark L. Faupel Ph.D. | Chief Executive Officer, President, Chief Operating Officer, Acting Chief Financial Officer, Secretary and Director |